NCT00245414View on ClinicalTrials.gov

Trial of Pegasys® in Patients With Chronic Hepatitis C

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions
Chronic Hepatitis C
Interventions
DRUG

Pegasys®

180μg for s.c./week for 48 weeks

DRUG

Pegasys®

180μg for s.c./week for 24 weeks

Trial Locations (6)

Unknown

Kyusyu Region, Fukuoka

Chugoku Region, Okayama

Kinki Region, Osaka

Hokkaido Region, Sapporo

Kanto Region, Tokyo

Tokai Region, Yamanashi

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY